Dr. Joan Camprodon is the inaugural Chief of the Division of Neuropsychiatry at Massachusetts General Hospital and Associate Professor of Psychiatry at Harvard Medical School. Board-certified in Psychiatry and Behavioral Neurology-Neuropsychiatry, Dr. Camprodon is the founding Director of the MGH Transcranial Magnetic Stimulation (TMS) clinical service, a member of the Psychiatric Neurosurgery Committee and an attending physician in the departments of Psychiatry (Neuropsychiatry) and Neurology (Cognitive and Behavioral Neurology).

Using an integrated clinical neuroscience model, his practice focuses on Neuromodulation, Neuropsychiatry and Behavioral Neurology. He cares for patients with comorbid neurological and psychiatric disorders and patients who present with atypical syndromes including disordered cognition, behavior and/or emotion in the context of known or suspected brain pathology. He also treats patients with severe and refractory psychiatric conditions using innovative device neuromodulation therapies. Dr. Camprodon directs the Laboratory for Neuropsychiatry and Neuromodulation, where he uses combinations of brain stimulation and neuroimaging/neurophysiology to investigate brain circuitry and neuroplasticity. One of Dr. Camprodon’s goals is to discover treatment targets that could result in the development of individualized precision therapeutics, with a focus on image-guided, device-based neuromodulation.

Dr. Camprodon studied Philosophy and Medicine at the University of Barcelona. After a neuroimaging research fellowship in the Department of Neurology at the Humboldt University in Berlin (Germany), he moved to Boston to pursue a PhD in Neuroscience in the Department of Neurology at Beth Israel Deaconess Medical Center and an MPH at the Harvard School of Public Health. He continued his research as junior faculty in the Department of Neurology at Harvard until he joined Mass General to complete a Psychiatry residency. He served as chief resident of the MGH Psychiatric Consultation Service and completed a clinical fellowship in Behavioral Neurology and Neuropsychiatry.

Dr. Daphne J. Holt is an Associate Professor of Psychiatry at Harvard Medical School, Co-Director of the Psychosis Clinical and Research Program, and Director of the Resilience and Prevention (RAP) Program and the Emotion and Social Neuroscience Laboratory, at MGH. Dr. Holt attended medical school at the University of Chicago Pritzker School of Medicine, where she also received a PhD in neurobiology. She received her training in adult psychiatry in the Massachusetts General/McLean Hospital Adult Psychiatry Residency Program, becoming a faculty member of the Massachusetts General Hospital Psychiatry Department in 2004. Dr. Holt’s research focuses on understanding the neural basis of emotional function and social behavior, and changes in these domains, in people who are affected by, or at risk for, serious mental illnesses. In addition, the RAP program she oversees is developing and testing interventions that may reduce risk for neuropsychiatric illness.

She has published peer-reviewed articles in journals such as JAMA Psychiatry, Molecular Psychiatry, Biological Psychiatry, Schizophrenia Bulletin, the Journal of Neuroscience, and NeuroImage, among others. Her research has been supported by grants from the National Institute of Mental Health, the Sidney R. Baer, Jr. Foundation, the Brain & Behavior Research Foundation, the MGH Executive Committee on Research (as a recipient of the Claflin Award and the MGH Research Scholar Award), the McCance Center for Brain Health and Mass General Neuroscience.